Analyst Reco. Novo Nordisk A/S Sao Paulo

Equities

Market Closed - Sao Paulo Other stock markets 16:11:00 2024-06-14 EDT			5-day change	1st Jan Change
95.34 ^BRL	+18.14%		-0.06%	+52.62%

06-14	Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy	RE
06-14	Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup	DJ

NOVO NORDISK : Deutsche Bank reiterates its Buy rating	06-14	ZD
Sector Update: Health Care	06-11	MT
Senate Committee to Vote June 18 to Subpoena Novo Nordisk President Doug Langa	06-11	MT
Argus Research Raises Novo Nordisk Price Target to $160 From $125, Maintains Buy Rating	06-10	MT
NOVO NORDISK : Buy rating by Goldman Sachs	05-30	ZD
NOVO NORDISK : Deutsche Bank reaffirms its Buy rating	05-28	ZD
NOVO NORDISK : JP Morgan reiterates its Buy rating	05-24	ZD
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell; Hims & Hers Health to Advance, AMC Entertainment to Decline	05-21	MT
NOVO NORDISK : UBS sticks Neutral	05-15	ZD
NOVO NORDISK : JP Morgan reaffirms its Buy rating	05-14	ZD
NOVO NORDISK : UBS reaffirms its Neutral rating	05-14	ZD
Stifel Lifts Novo Nordisk PT, Keeps Buy Recommendation	05-14	MT
NOVO NORDISK : Stifel raises its target price	05-14	CF
Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US	05-13	MT
Novo Nordisk Plans First Bond Sale in 2 Years	05-13	MT
NOVO NORDISK : Berenberg reiterates its Neutral rating	05-08	ZD
Novo Nordisk Seeks More Time to Address US Sen. Bernie Sanders' Questions on Drug Pricing	05-07	MT
NOVO NORDISK : Barclays remains its Buy rating	05-07	ZD
NOVO NORDISK : UBS sticks Neutral	05-06	ZD
Novo Nordisk: share price falls, analyst adjusts target	05-03	CF